Intensification of a suppressive HAART regimen increases CD4 counts and decreases CD8+ T-cell activation
- PMID: 17997138
- DOI: 10.1016/j.clim.2007.10.002
Intensification of a suppressive HAART regimen increases CD4 counts and decreases CD8+ T-cell activation
Abstract
A significant proportion of HIV-1-infected individuals on suppressive HAART regimens do not reconstitute CD4 counts well. If viral reservoirs persist and impact on CD4 reconstitution in a percentage of cases then addition of another antiretroviral agent could further suppress these reservoirs resulting in enhanced CD4 recovery. To evaluate this possibility, we studied the effect of adding abacavir to a chronically suppressive NNRTI containing HAART regimen for 8 patients on their CD4 count and expression of activation markers. Over the first 24 weeks of intensification, CD4 counts increased significantly (p=0.028). This increase continued after a year in follow-up with a significant rate of change in CD4 T-cells of 0.959+/-1.27 per week. In addition, during intensification changes in the percentage of CD38+CD8+ T-cells over time were significantly negatively correlated with changes in CD4 cell number over time above increases predicted without intensification (r(2)=0.716, p=0.008). These data support the possibility that in certain cases where suboptimal CD4 reconstitution occurs that intensification of the regimen can impact immunologic parameters.
Similar articles
-
CD38+CD8+ T-cells negatively correlate with CD4 central memory cells in virally suppressed HIV-1-infected individuals.AIDS. 2008 Oct 1;22(15):1937-41. doi: 10.1097/QAD.0b013e32830f97e2. AIDS. 2008. PMID: 18784457
-
Treatment intensification with raltegravir in subjects with sustained HIV-1 viraemia suppression: a randomized 48-week study.Antivir Ther. 2012;17(2):355-64. doi: 10.3851/IMP1917. Epub 2011 Sep 28. Antivir Ther. 2012. PMID: 22290239 Clinical Trial.
-
[Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].Zhonghua Yi Xue Za Zhi. 2007 Nov 13;87(42):2973-6. Zhonghua Yi Xue Za Zhi. 2007. PMID: 18261327 Clinical Trial. Chinese.
-
[Effect of highly active antiretroviral therapy on the immune system in patients with HIV infection].Ter Arkh. 2002;74(11):80-2. Ter Arkh. 2002. PMID: 12498138 Review. Russian. No abstract available.
-
Is weak CD4+ gain in the course of suppressive combination antiretroviral therapy for HIV infection a current clinical challenge? A case report and brief review of the literature.BMC Infect Dis. 2018 Jan 5;18(1):8. doi: 10.1186/s12879-017-2942-3. BMC Infect Dis. 2018. PMID: 29304776 Free PMC article. Review.
Cited by
-
Antiretroviral therapy suppressed participants with low CD4+ T-cell counts segregate according to opposite immunological phenotypes.AIDS. 2016 Sep 24;30(15):2275-87. doi: 10.1097/QAD.0000000000001205. AIDS. 2016. PMID: 27427875 Free PMC article.
-
CD4:CD8 ratio and CD8+ cell count for prognosticating mortality in HIV-infected patients on antiretroviral therapy.J Lab Precis Med. 2018 Feb;3:8. doi: 10.21037/jlpm.2018.01.10. Epub 2018 Feb 2. J Lab Precis Med. 2018. PMID: 30167571 Free PMC article. No abstract available.
-
HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects.Nat Med. 2010 Apr;16(4):460-5. doi: 10.1038/nm.2111. Epub 2010 Mar 14. Nat Med. 2010. PMID: 20228817
-
EBV-specific CD8+ T cells from asymptomatic pediatric thoracic transplant patients carrying chronic high EBV loads display contrasting features: activated phenotype and exhausted function.J Immunol. 2011 May 15;186(10):5854-62. doi: 10.4049/jimmunol.1001024. Epub 2011 Apr 1. J Immunol. 2011. PMID: 21460204 Free PMC article.
-
Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy.AIDS. 2010 Oct 23;24(16):2451-60. doi: 10.1097/QAD.0b013e32833ef7bb. AIDS. 2010. PMID: 20827162 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials